FindTrial
Sign In

Comparison of effect of Early switch over versus Late switchover from intravitreal anti VEGF injection to intravitreal dexamethasone in patient with Diabetic macular edema

A Comparative Study of early Switch versus Late Switch of Intravitreal Dexamethasone in Diabetic macular edema - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065744
Enrollment
88
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

dr sunil das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of Diabetic macular edema Patients who have taken atleast 1 intravitreal injection of Anti VEGF

Exclusion criteria

Exclusion criteria: Prio intravitrral dexamethasone injection Active intraocular inflammation and infection

Design outcomes

Primary

MeasureTime frame
Mean best corrected visual acuity at 1month 3months 6months 1yearTimepoint: Mean best corrected visual acuity—

Secondary

MeasureTime frame
Mean change in Central Retinal ThicknessTimepoint: 12months—

Countries

India

Contacts

Public ContactDr Monika kapoor

nethradhama superspecialaity eye hospital

dr.monika.kapoor@gmail.com9811866335

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026